Your Messages Inbox
Your Article Summary
See Latest Articles(Click the title below to leave the MDLinx Network and go to the Journal's Website)
Acura and King Receive FDA Complete Response Letter Regarding Acurox
King Pharmaceuticals, 07/06/09
Acura Pharmaceuticals, Inc. and King Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration has issued a Complete Response Letter regarding the New Drug Application for Acurox Tablets CII, an immediate release product intended for the relief of moderate-to-severe pain.
Today in Regulatory Issues...keeping you current
Receive free subspecialty "5-minute updates" via email
Advisory Committee briefing materials for CRESTOR sNDA available on US FDA web site
AstraZeneca, 12/15/09
Sixteen Fired for Records Snooping
HealthDataManagement, 12/09/09
Watson Files FDA Application for Generic Rozerem
Watson Pharmaceuticals, 12/07/09
Article Search
Sponsor